Marks JR, Zhang D, Hardman T, Chen YY, et al. Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance). Breast Cancer Res 2025;27:26.
PMID: 39980051